- Home
- UL vs LLY Comparison
UL vs LLY Comparison
Compare UL & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UL | LLY |
|---|---|---|
| Founded | 1930 | 1876 |
| Country | United Kingdom | United States |
| Employees | 96092 | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.2B | 818.6B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | UL | LLY |
|---|---|---|
| Price | $58.02 | $907.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 19 |
| Target Price | N/A | ★ $1,217.79 |
| AVG Volume (30 Days) | ★ 5.4M | 2.3M |
| Earning Date | 07-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.97% | 0.75% |
| EPS Growth | N/A | ★ 95.99 |
| EPS | N/A | ★ 22.95 |
| Revenue | N/A | ★ $65,179,000,000.00 |
| Revenue This Year | $2.60 | $26.98 |
| Revenue Next Year | $3.70 | $15.83 |
| P/E Ratio | ★ $14.29 | $40.14 |
| Revenue Growth | N/A | ★ 44.70 |
| 52 Week Low | $54.95 | $623.78 |
| 52 Week High | $74.98 | $1,133.95 |
Technical Indicators
Market Signals| Indicator | UL | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 36.54 | 40.42 |
| Support Level | $55.00 | $877.11 |
| Resistance Level | $61.41 | $1,102.49 |
| Average True Range (ATR) | 0.96 | 27.52 |
| MACD | 0.39 | 3.27 |
| Stochastic Oscillator | 52.82 | 29.66 |
Price Performance
Historical ComparisonAbout UL Unilever PLC
Unilever is a diversified beauty, wellbeing, and personal care (51% of 2025 sales by value), homecare (23%), and packaged food (26%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.